Results 241 to 250 of about 5,850,068 (304)

Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

International Journal of Gynecology &Obstetrics, EarlyView.
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto, Martha Gulati, Suvarna S. Khadilkar, Angela H. E. M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea R. Genazzani, Hema Divakar, Athena Poppas, on behalf of the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO)   +9 more
wiley   +1 more source

Atherosclerotic cardiovascular disease risk is associated with AT(N)V neuroimaging biomarkers and cognitive impairment in the health and aging brain study-health disparities cohort. [PDF]

Front Aging Neurosci
Espejo K, Rulkens R, Hayes CA, Contreras JA.   +3 more
europepmc   +1 more source

Lactobacillus johnsonii attenuates ovarian aging by remodeling the gut–ovary axis

iMetaOmics, EarlyView.
Aging is accompanied by a reduced abundance of L. johnsonii and ovarian decline. Supplementation with L. johnsonii elevates microbial IPA production via the LdhA enzyme and commensal bacteria. IPA activates the AhR/YAP signaling axis, promoting YAP nuclear translocation and inducing the expression of downstream target genes CYR61 and CTGF. This cascade
Jiamin He, Qiwen Wang, Luyi Chen, Yadong Qi, Dingjiacheng Jia, Jilei Xu, Qingyi Wang, Yao Jiang, Jian Zhou, Yong Sun, Ruochen Yan, Lan Wang, Tongyao Hou, Zheng Kuang, Min Jin, Liangjing Wang, Shujie Chen   +16 more
wiley   +1 more source

Decoding the shared genetic architecture of atherosclerotic cardiovascular disease: a genomic structural equation modeling analysis. [PDF]

BMC Cardiovasc Disord
Zhong D, Ye Y, Ye T, Jin S.
europepmc   +1 more source

Efficacy and safety of alirocumab once-monthly in patients with atherosclerotic cardiovascular disease and without history of an acute atherothrombotic event. [PDF]

Am J Prev Cardiol
Tokgözöğlu L, Arbel Y, Lozano CB, Martens F, Stach K, Orsini M, Tavori H, Cainzos-Achirica M, Rassaf T, Perrone-Filardi P, Vrablík M.   +10 more
europepmc   +1 more source

Performance of Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the <i>All of Us</i> Program. [PDF]

Circ Genom Precis Med
Smith JL, Norland K, Hamed ME, Yu Y, Na J, Dikilitas O, Schaid DJ, Kullo IJ.   +7 more
europepmc   +1 more source

Managing Progressive Atherosclerotic Cardiovascular Disease in a Patient with Elevated Lipoprotein(a). [PDF]

Anatol J Cardiol
Yurtseven E, Tokgözoğlu L.
europepmc   +1 more source

Association Between Predicted 10-Year Atherosclerotic Cardiovascular Disease Risk and Magnetic Resonance Imaging-Defined Covert Brain Infarction. [PDF]

J Stroke
Gao P, Wang X, Ren L, Zhou M, Zhang R, Cai X, Yang Y, Sun J, Wang Y, Wang Y, Pan Y.   +10 more
europepmc   +1 more source